Dimensional Fund Advisors LP Alaunos Therapeutics, Inc. Transaction History

Dimensional Fund Advisors LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 09, 2023	SELL	$0.43 - $0.65 $411 - $621	-956 Reduced 1.05%	90,379 $46,000
Q3 2022 Nov 10, 2022	SELL	$1.04 - $322.5 $14,567 - $4.52 Million	-14,007 Reduced 13.3%	91,335 $157,000
Q4 2021 Feb 09, 2022	BUY	$1.09 - $1.89 $1,325 - $2,298	1,216 Added 1.17%	105,342 $115,000
Q3 2021 Nov 12, 2021	SELL	$1.44 - $2.73 $95,283 - $180,641	-66,169 Reduced 38.86%	104,126 $190,000
Q2 2021 Aug 12, 2021	SELL	$2.63 - $3.67 $5,762 - $8,040	-2,191 Reduced 1.27%	170,295 $450,000
Q1 2021 May 14, 2021	BUY	$2.82 - $5.6 $404,630 - $803,521	143,486 Added 494.78%	172,486 $621,000
Q4 2020 Feb 25, 2021	BUY	$2.09 - $3.09 $60,609 - $89,610	29,000 New	29,000 $73,000

92.6K

Ticker TCRT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 216,182,000
Market Cap $424M
Description
Alaunos Therapeutics, Inc., a clinical-stage oncology-focused cell therapy company, develops adoptive TCR engineered T-cell therapies. It develops TCR Library, which is in Phase I/II clinical trial for ten TCRs reactive to mutated KRAS, TP53, and EGFR from its TCR library for the treatment of non-small cell lung, colorectal, endometrial, pancrea...

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

Stay updated on Dimensional Fund Advisors LP with notifications on news.